Opioid free anaesthesia in lumbar microscopic discectomy and comparing bilateral erector spinae plane block and intravenous lignocaine infusion for post operative pain management
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/01/061553
- Lead Sponsor
- Himalayan Institute Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Age 18-65 years
2)All patients giving written consent will be taken for study
3)American Society of Anaesthesiology physical status grade 1 to 3
Exclusion Criteria
1)Allergy to local anaesthetic drug or any other drug used in the study
2)MI within 6 months, profoundly decreased LVEF( <40%), cardiac failure(NYHA 1 to 4)
3)Severe liver disease(AST OR ALT or bilirubin >2.5 times the upper limit of normal)
4)Renal failure(creatinine outside normal range)
5)Patients who cannot operate PCA pump
6)Chronic use of opioids and beta blockers
7)Chronic pain syndromes
8)Inability to understand pain assessment
9)Pregnancy and lactation
10)Severe mental impairment, known psychiatric illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the post-operative pain outcome using numerical rating scale (NRS) after erector spinae plane block and intravenous lignocaine infusion and its comparison with the control group in microscopic lumbar discectomyTimepoint: To assess the post-operative pain outcome using numerical rating scale (NRS) after erector spinae plane block and intravenous lignocaine infusion and its comparison with the control group in microscopic lumbar discectomy at 0, at. 30 minutes,1,2,3,4,5,6,8,10,12,16,20,24 hours
- Secondary Outcome Measures
Name Time Method To assess the quality of recovery and post-operative outcome using QOR-15 score and S-DN4 questionnaireTimepoint: QOR-15 score will be assessed preoperatively, postoperatively and at 3 Months <br/ ><br>S-DN4 questionnaire will be assessed at 3 months